In 2023, leukemia mortality among males in Brazil was recorded at an unspecified value. For the years from 2024 to 2028, there is a projected steady increase in mortality from 4.02 to 4.15 thousand male deaths. This translates to year-on-year growth rates of approximately 0.75% to 1.00%. The compound annual growth rate (CAGR) over these five years is moderate, reflecting ongoing health challenges associated with this disease.

Future trends to watch for:

Advancements in medical treatment and their impact on reducing mortality rates.
Government and healthcare policies targeting cancer prevention and early detection.
Demographic shifts and their influence on leukemia incidence and outcomes.